Structure-based design and activity modeling of novel epidermal growth factor receptor kinase inhibitors; an in silico approach

The development of EGFR kinase inhibitors to treat non-small cell lung cancers is an important medical necessity due to persistent development of resistance by the mutations. In-view of this, a model with a very high predictive ability on thirty (30) EGFR kinase inhibitors was built using QSAR molec...

Full description

Bibliographic Details
Main Authors: Muhammad Tukur Ibrahim, Adamu Uzairu, Gideon Adamu Shallangwa, Sani Uba
Format: Article
Language:English
Published: Elsevier 2020-09-01
Series:Scientific African
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2468227620302416